David A. Peterson

Dr. David A. Peterson

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 August 2013 in Neurology
Verified
Journal Article
Closed access
PDF file
DPDavid A. Peterson
David A. Peterson
PBPatrice Berque
Patrice Berque
HJHans-Christian Jabusch
Hans-Christian Jabusch
EAEckart Altenmüller
Eckart Altenmüller
SFSteven J. Frucht
Steven J. Frucht
Musician9s dystonia (MD) is a focal adult-onset dystonia most commonly involving the hand. It has much greater relative prevalence than non-musician’s focal hand dystonias, exhibits task specificity at the level of specific musical passages, and is a particularly difficult form of dystonia to treat. For most MD patients, the diagnosis confirms the end of their music performance careers. Research on treatments and pathophysiology is contingent upon measures of motor function abnormalities. In this review, we comprehensively survey the literature to identify the rating scales used in MD and the distribution of their use. We also summarize the extent to which the scales have been evaluated for their clinical utility, including reliability, validity, sensitivity, specificity to MD, and practicality for a clinical setting. Out of 135 publications, almost half (62) included no quantitative measures of motor function. The remaining 73 studies used a variety of choices from among 10 major rating scales. Most used subjective scales involving either patient or clinician ratings. Only 25% (18) of the studies used objective scales. None of the scales has been completely and rigorously evaluated for clinical utility. Whether studies involved treatments or pathophysiologic assays, there was a heterogeneous choice of rating scales used with no clear standard. As a result, the collective interpretive value of those studies is limited because the results are confounded by measurement effects. We suggest that the development and widespread adoption of a new clinically useful rating scale is critical for accelerating basic and clinical research in MD.

15 November 2016 in Neurology
Verified
Journal Article
Closed access
PDF file
DPDavid A. Peterson
David A. Peterson
GLGwen C. Littlewort
Gwen C. Littlewort
MBMarian S. Bartlett
Marian S. Bartlett
AMAntonella Macerollo
Antonella Macerollo
JPJoel S. Perlmutter
Joel S. Perlmutter
TSTerrence J. Sejnowski
Terrence J. Sejnowski
Objective: To compare clinical rating scales of blepharospasm severity with involuntary eye closures measured automatically from patient videos with contemporary facial expression software. Methods: We evaluated video recordings of a standardized clinical examination from 50 patients with blepharospasm in the Dystonia Coalition9s Natural History and Biorepository study. Eye closures were measured on a frame-by-frame basis with software known as the Computer Expression Recognition Toolbox (CERT). The proportion of eye closure time was compared with 3 commonly used clinical rating scales: the Burke-Fahn-Marsden Dystonia Rating Scale, Global Dystonia Rating Scale, and Jankovic Rating Scale. Results: CERT was reliably able to find the face, and its eye closure measure was correlated with all of the clinical severity ratings (Spearman ρ = 0.56, 0.52, and 0.56 for the Burke-Fahn-Marsden Dystonia Rating Scale, Global Dystonia Rating Scale, and Jankovic Rating Scale, respectively, all p < 0.0001). Conclusions: The results demonstrate that CERT has convergent validity with conventional clinical rating scales and can be used with video recordings to measure blepharospasm symptom severity automatically and objectively. Unlike EMG and kinematics, CERT requires only conventional video recordings and can therefore be more easily adopted for use in the clinic.

7 March 2017 in Frontiers in Computational Neuroscience
Verified
Journal Article
Open access
DPDavid A. Peterson
David A. Peterson
TSTerrence J. Sejnowski
Terrence J. Sejnowski
Blepharospasm (sometimes called “benign essential blepharospasm”, BEB) is one of the most common focal dystonias. It involves involuntary eyelid spasms, eye closure, and increased blinking. Despite the success of botulinum toxin injections and, in some cases, pharmacologic or surgical interventions, BEB treatments are not completely efficacious and only symptomatic. We could develop principled strategies for preventing and reversing the disease if we knew the pathogenesis of primary BEB. The objective of this study was to develop a conceptual framework and dynamic circuit hypothesis for the pathogenesis of BEB. The framework extends our overarching theory for the multifactorial pathogenesis of focal dystonias (Peterson and Sejnowski 2010 Neurobiol Dis) to incorporate a two-hit rodent model specifically of BEB (Schicatano, Basso, and Evinger 1997 J Neurophysiol). We incorporate in the framework three features critical to cranial motor control: 1) the joint influence of motor cortical regions and direct descending projections from one of the basal ganglia output nuclei, the substantia nigra pars reticulata, on brainstem motor nuclei, 2) nested loops composed of the trigeminal blink reflex arc and the long sensorimotor loop from trigeminal nucleus through thalamus to somatosensory cortex back through basal ganglia to the same brainstem nuclei modulating the reflex arc, and 3) abnormalities in the basal ganglia dopamine system that provide a sensorimotor learning substrate which, when combined with patterns of increased blinking, leads to abnormal sensorimotor mappings manifest as BEB. The framework explains experimental data on the trigeminal reflex blink excitability (TRBE) from Schicatano et al. and makes predictions that can be tested in new experimental animal models based on emerging genetics in dystonia, including the recently characterized striatal-specific D1R dopamine transduction alterations caused by the GNAL mutation. More broadly, the model will provide a guide for future efforts to mechanistically link multiple factors in the pathogenesis of BEB and facilitate simulations of how exogenous manipulations of the pathogenic factors could ultimately be used to prevent and reverse the disorder.

8 January 2021 in Journal of Neurology
Verified
Journal Article
Closed access
PDF file
JVJeanne Vu
Jeanne Vu
HLHa Yeon Lee
Ha Yeon Lee
QCQiyu Chen
Qiyu Chen
ECElizabeth Cisneros
Elizabeth Cisneros
RBRichard L. Barbano
Richard L. Barbano
DPDavid A. Peterson
David A. Peterson

25 March 2022 in Annals of Clinical and Translational Neurology
Verified
Journal Article
Open access
ZZZheng Zhang
Zheng Zhang
ECElizabeth Cisneros
Elizabeth Cisneros
HLHa Yeon Lee
Ha Yeon Lee
JVJeanne P. Vu
Jeanne P. Vu
QCQiyu Chen
Qiyu Chen
DPDavid A. Peterson
David A. Peterson
Objective: Deviated head posture is a defining characteristic of cervical dystonia (CD). Head posture severity is typically quantified with clinical rating scales such as the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS). Because clinical rating scales are inherently subjective, they are susceptible to variability that reduces their sensitivity as outcome measures. The variability could be circumvented with methods to measure CD head posture objectively. However, previously used objective methods require specialized equipment and have been limited to studies with a small number of cases. The objective of this study was to evaluate a novel software system—the Computational Motor Objective Rater (CMOR)—to quantify multi‐axis directionality and severity of head posture in CD using only conventional video camera recordings.Methods: CMOR is based on computer vision and machine learning technology that captures 3D head angle from video. We used CMOR to quantify the axial patterns and severity of predominant head posture in a retrospective, cross‐sectional study of 185 patients with isolated CD recruited from 10 sites in the Dystonia Coalition.Results: The predominant head posture involved more than one axis in 80.5% of patients and all three axes in 44.4%. CMOR's metrics for head posture severity correlated with severity ratings from movement disorders neurologists using both the TWSTRS‐2 and an adapted version of the Global Dystonia Rating Scale (rho = 0.59–0.68, all p <0.001).Conclusions: CMOR's convergent validity with clinical rating scales and reliance upon only conventional video recordings supports its future potential for large scale multisite clinical trials.

22 January 2022 in Journal of the Neurological Sciences
Verified
Journal Article
Closed access
JVJeanne P. Vu
Jeanne P. Vu
ECElizabeth Cisneros
Elizabeth Cisneros
HLHa Yeon Lee
Ha Yeon Lee
LLLinh Le
Linh Le
QCQiyu Chen
Qiyu Chen
DPDavid A. Peterson
David A. Peterson